Abstract

BackgroundAllogeneic stem cell transplantation (alloSCT) is the preferred option of postremission therapy for high-risk patients suffering from acute myeloid leukemia (AML). Therefore, monitoring life satisfaction (LS) of long-term survivors following alloSCT is becoming increasingly important for oncologists. The aim of the study was to evaluate individual survivor priority of various general and health-related domains of life and their satisfaction with these domains. Furthermore, we investigated the impact of general and health-related LS on resilience, anxiety, depression and quality of life in AML survivors following alloSCT.MethodsForty-one AML survivors (median age at time of assessment = 49.0 years) who had undergone alloSCT (median time since transplantation = 3.1 years) were enrolled in the study. Psychosocial parameters were assessed using the following instruments: FLZM (Questions on Life Satisfaction), EORTC QLQ-C30, HADS (Hospital Anxiety and Depression Scale) and the RS-25 (Resilience Scale-25 items). Correlation analyses were computed to reveal the associations between the different questionnaires.ResultsIndependence from help or care, well-regulated living conditions and financial security contributed positively to LS, whereas being off work due to health-reasons and dissatisfaction with physical aspects were negatively associated to the subjective feelings of overall satisfaction. Moreover, a high quality of life was strongly positively correlated with LS (Spearman’s rho general LS: 0.643 and health-related LS: 0.726, both p < 0.001). A high degree of resilience was also strongly positively correlated with better LS (general LS: 0.700, health-related LS: 0.675, both p < 0.001). Symptoms of anxiety and depression were associated with an impaired general LS (anxiety: −0.674, depression: −0.698, both p < 0.001).ConclusionsOur results indicate that LS should be considered an important key contributor to the survivors’ well-being following alloSCT. Thus, identifying protective psychological and physical factors that relieve stressors is of high importance in order to support long-term AML survivors with their special needs.

Highlights

  • Allogeneic stem cell transplantation is the preferred option of postremission therapy for high-risk patients suffering from acute myeloid leukemia (AML)

  • Due to continuous optimization of chemotherapy and supportive care, the prognosis for patients suffering from acute myeloid leukemia (AML) has steadily improved over the last decades

  • Study sample We identified a total of 41 AML survivors, aged 23– 66 years at time of assessment, who fulfilled the questionnaires

Read more

Summary

Introduction

Allogeneic stem cell transplantation (alloSCT) is the preferred option of postremission therapy for high-risk patients suffering from acute myeloid leukemia (AML). Monitoring life satisfaction (LS) of long-term survivors following alloSCT is becoming increasingly important for oncologists. We investigated the impact of general and health-related LS on resilience, anxiety, depression and quality of life in AML survivors following alloSCT. Only a few studies have analyzed quality of life in AML survivors following alloSCT [8,9,10]. Grulke et al analyzed quality of life before and after autologous or allogeneic haematopoietic stem cell transplantation from 33 publications which included about 2800 patients. Their results showed that quality of life decreased directly following transplantation, increased as date of discharge approached and continued to improve thereafter. Quality of life levels measured a year later were comparable to those measured a few weeks prior to transplantation [12]

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call